{"id":"W3088796366","doi":"10.1016/j.annonc.2020.08.950","title":"811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Internal medicine; Progression-free survival; Ovarian cancer; Randomization; Oncology; Chemotherapy; Urology; Cancer; Gastroenterology; Surgery; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001884721,0.0001907199,0.0004804769,0.0002262315,0.0002600376,0.0003637348,0.0001758731,0.0002710442,0.002581618],"category_scores_gemma":[0.0003022991,0.00008535041,0.0004559737,0.0002620633,0.0001008316,0.0002679783,0.0002095809,0.0004541379,0.0003532473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003954653,"about_ca_system_score_gemma":0.0004651463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001103558,"about_ca_topic_score_gemma":0.003318046,"domain_scores_codex":[0.999913,0.00001416672,0.000005845433,0.00002427134,0.00001166649,0.00003105962],"domain_scores_gemma":[0.9998542,0.00002008458,0.00003257568,0.000009093253,0.000009278006,0.00007473008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2074404,0.004050753,0.3158831,0.0004799491,0.001088815,0.001425815,0.0002054471,0.001604629,0.01658537,0.0003190578,0.008697198,0.4422195],"study_design_scores_gemma":[0.01577912,0.05920504,0.8982887,0.0001679601,0.00106721,0.002751294,0.0002171804,0.00203456,0.003256783,0.0006262572,0.01656258,0.0000431749],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937596,0.001979042,0.0001024599,0.0002676889,0.00005515633,0.00005120589,0.001127195,0.00001815991,0.002639409],"genre_scores_gemma":[0.9948838,0.0008637058,0.0001344225,0.0002519869,0.00005071062,0.00004162039,0.001971475,0.000004015802,0.001798235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002581618,"threshold_uncertainty_score":0.008636415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05051790121081382,"score_gpt":0.3524662552589584,"score_spread":0.3019483540481445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}